Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Articles by Joaquin Duato
Johnson & Johnson: Johnson & Johnson's Prostate Cancer Drug JNJ-6143 Shrinks Tumours In Early Trial
Johnson & Johnson is a New Jersey-based firm that engages in research, manufacturing and sale of healthcare products including consumer, pharmaceutical and medical devices.
Johnson & Johnson CEO: America’s innovation advantage starts with health Original
Over the past century, American innovation has transformed healthcare, turning once-unimaginable ideas into lifesaving realities for patients around the world. As the United States approaches its 250th anniversary, that legacy is not slowing down. After decades working at the intersection of science, manufacturing, and patient care, I see every day that America’s capacity for innovation is not fading. It is gaining momentum. What sets the United States apart is not invention alone.
Johnson & Johnson CEO: America’s innovation advantage starts with health
Over the past century, American innovation has transformed healthcare, turning once-unimaginable ideas into lifesaving realities for patients around the world. As the United States approaches its 250th anniversary, that legacy is not slowing down. After decades working at the intersection of science, manufacturing, and patient care, I see every day that America’s capacity for innovation is not fading. It is gaining momentum. What sets the United States apart is not invention alone.
J&J Drug for Rare Infant Blood Disorder Achieves Main Goal of Phase 2 Test
A Johnson & Johnson drug acquired as part of a $6.5 billion deal has preliminary data showing it met the main goal of a mid-stage test in a rare blood disorder that can become fatal to fetuses. Full data from the trial will be presented at a future scientific meeting.
USA-Les valeurs à suivre à Wall Street
PARIS, 1er décembre (Reuters) - Principales valeurs à suivre jeudi à Wall Street : * SALESFORCE CRM.N a annoncé la démission de son codirection général et vice-président, Bret Taylor, et que le cofondateur Marc Benioff resterait seul à la tête de l'entreprise spécialisée dans les logiciels de la relation client. L'action reculait de 6,4% dans les échanges en avant-Bourse.
Supporting today’s youth to create tomorrow’s advocates
During the past few weeks, we have seen young people across the country demonstrate their desire to engage in political debate to drive policy change. They have led marches, moments of reflection and prayer, social media campaigns, direct lobbying efforts and press conferences on Capitol Hill and in many state capitols across America. These emerging leaders, most still teenagers, have made their voices heard.
Our children, our future - bridging the partisan divide
This week, as they did last week in Cleveland, hundreds of interest groups and lobbyists will be in Philadelphia for the presidential convention. However, one critical group is not present – our children. Our children’s future is our future, and therefore a crucial element to consider when solving the challenges facing our nation. Studies show the human brain develops most rapidly between birth and age 5, yet almost all public investments in children happen after the age of 5.
Show More
loading
Actions
Is this you?
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.Get in touch with Joaquin
Contact Joaquin, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack